Dr. James B. Potash

Dr. Potash returned to Johns Hopkins as Director of Psychiatry and Psychiatrist-in-Chief in 2017. Prior to that he was Chair and Department Executive Officer of the University of Iowa Department of Psychiatry from 2011-17. Dr. Potash graduated in 1984 from Yale College, where he majored in English. Following graduation, he served in the Peace Corps in the West African country of Senegal, and there decided to become a physician. He completed his master’s degree in public health at Johns Hopkins, focusing on epidemiology and international health. He then went on to medical school at Hopkins, medical internship at Hopkins Bayview, and a year working as a general practitioner in another West African country, Benin. He returned to do his psychiatric residency at Hopkins and served as chief resident in 1997-98. He then joined Dr. Ray DePaulo’s mood disorders program, and eventually became the program’s research director before moving to Iowa. Dr. Potash’s work has focused on investigation of the genetic and epigenetic basis of mood disorders—depression and bipolar disorder. These efforts have resulted in over 170 publications and consistent NIH funding. He has been particularly interested in the genetic basis of the psychotic forms of bipolar disorder, and in the epigenetic mechanisms through which stress plays a role in depression. Dr. Potash co-leads the Bipolar Sequencing Consortium, and is a member of the Council on Research for the American Psychiatric Association. He serves as Treasurer for the International Society for Psychiatric Genetics, and he has played a leading role in the National Network of Depression Centers. In addition to his research endeavors, Dr. Potash is also an active clinician who sees mood disorders patients in the inpatient and outpatient settings.

Dr. Potash is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizophrenia, and Autism Spectrum Disorder.

His clinical research consists of co-authoring 150 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 26 articles in the study of Schizophrenia.